✦ LIBER ✦

Comparison of Immunohistochemical and Fluorescence In Situ Hybridization Assessment for HER-2/neu Status in Taiwanese Breast Cancer Patients

✍ Scribed by Shou-Jen Kuo; Boris Bao-Tyan Wang; Cheng-Shyong Chang; Tze-Ho Chen; Kun-Tu Yeh; Dong-Jay Lee; Pao-Lun Yin; Ming Chen

Book ID: 117696917
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 111 KB
Volume: 46
Category: Article
ISSN: 1028-4559
DOI: 10.1016/s1028-4559(07)60008-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reliability of chromogenic in situ hybri

Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility

✍ Gong, Yun; Gilcrease, Michael; Sneige, Nour 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB

0025 A comparative study of immunohistoc

0025 A comparative study of immunohistochemical staining and fluorescence in situ hybridization method of HER-2/neu in breast cancer

✍ M. Koo; B. Moon; K. Choi; C. Yom; Y. Park 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Chromogenic in situ hybridization for He

Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization

✍ Doris Mayr; Sibylle Heim; Kerstin Weyrauch; Evelyn Zeindl-Eberhart; Anne Kunz; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Comparison between immunohistochemistry

Comparison between immunohistochemistry and chromogenic in situ hybridization in assessing HER-2 status in breast cancer

✍ Nataša Todorović-Raković; Danica Jovanović; Zora Nešković-Konstantinović; Dragic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Comparison of in situ hybridization meth

Comparison of in situ hybridization methods for the assessment of HER-2/neu gene amplification status in breast cancer using a tissue microarray

✍ Anna Malicka-Durczak; Konstanty Korski; Matthew Ibbs 📂 Article 📅 2012 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 775 KB

Comparison of HER-2 status determined by

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

✍ Yun Gong; Daniel J. Booser; Nour Sneige 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Accurate assessment of __HER‐2__ status is necessary prior to anti‐__HER‐2__ antibody (trastuzumab) therapy for metastatic breast carcinoma. However, controversy exists regarding whether to assess __HER‐2__ status in the primary tumor or in metastatic lesions. It is also